Journey Medical Corp.

{
  "main_header": {
    "sid": 1286808,
    "name": "Journey Medical Corp.",
    "stock_name": "Journey Medical Corp.",
    "full_name": "Journey Medical Corp.",
    "name_url": "stocks-analysis/journey-medical-corp",
    "exchange": 1,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "8.35",
    "chg": 1.19,
    "chgp": "16.62%",
    "dir": 1,
    "prev_price": "7.16",
    "mcapval": "187.48",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US48115J1097",
    "curr_date": "Feb 05",
    "curr_time": "",
    "bse_nse_vol": "53.43 k",
    "exc_status": "Active",
    "traded_date": "Feb 05, 2026",
    "traded_date_str": "2026 02 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/journey-medical-corp-1286808-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Journey Medical Corp. Experiences Revision in Stock Score Amid Mixed Financial Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/journey-medical-corps-financial-trend-improves-from-flat-to-positive-amid-rising-sales-and-cash-flow-3715758",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JourneyMedicalC_fintrenddot_3715758.png",
        "date": "2025-11-19 15:49:56",
        "description": "Journey Medical Corp. has reported flat financial performance for the quarter ending June 2025, with strong revenue generation reflected in net sales of USD 15.01 million and improved operating cash flow. However, rising interest expenses and declines in pre-tax and net profit indicate ongoing profitability challenges. The stock has significantly outperformed the S&P 500 year-to-date."
      },
      {
        "title": "Journey Medical Corp. Hits New 52-Week High of $9.40",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/journey-medical-corp-hits-new-52-week-high-of-940-3698054",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JourneyMedicalC_priceRelatedfactors_3698054.png",
        "date": "2025-11-13 16:09:27",
        "description": "Journey Medical Corp. achieved a new 52-week high of USD 9.40 on November 12, 2025, reflecting a significant increase from its low of USD 3.54. With a market cap of USD 184 million, the company has a low debt-to-equity ratio but is currently loss-making and does not offer dividends."
      },
      {
        "title": "Journey Medical Corp. Hits New 52-Week High of $9.38",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/journey-medical-corp-hits-new-52-week-high-of-938-3693011",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JourneyMedicalC_priceRelatedfactors_3693011.png",
        "date": "2025-11-12 16:15:22",
        "description": "Journey Medical Corp. achieved a new 52-week high of USD 9.38 on November 11, 2025, reflecting a significant performance increase over the past year. With a market cap of USD 184 million, the company has a low debt-to-equity ratio but is currently operating at a loss."
      }
    ],
    "total": 10,
    "sid": "1286808",
    "stock_news_url": "https://www.marketsmojo.com/news/journey-medical-corp-1286808"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Journey Medical Corp. Experiences Revision in Stock Score Amid Mixed Financial Indicators

2025-11-19 15:49:56

Journey Medical Corp. has reported flat financial performance for the quarter ending June 2025, with strong revenue generation reflected in net sales of USD 15.01 million and improved operating cash flow. However, rising interest expenses and declines in pre-tax and net profit indicate ongoing profitability challenges. The stock has significantly outperformed the S&P 500 year-to-date.

Read full news article

Journey Medical Corp. Hits New 52-Week High of $9.40

2025-11-13 16:09:27

Journey Medical Corp. achieved a new 52-week high of USD 9.40 on November 12, 2025, reflecting a significant increase from its low of USD 3.54. With a market cap of USD 184 million, the company has a low debt-to-equity ratio but is currently loss-making and does not offer dividends.

Read full news article

Journey Medical Corp. Hits New 52-Week High of $9.38

2025-11-12 16:15:22

Journey Medical Corp. achieved a new 52-week high of USD 9.38 on November 11, 2025, reflecting a significant performance increase over the past year. With a market cap of USD 184 million, the company has a low debt-to-equity ratio but is currently operating at a loss.

Read full news article

View All News